Announcement:

A recent study by a team at Unilever has demonstrated the predictive power of NAM approaches for the comprehensive safety assessment of compounds by combining in vitro models with advanced computational techniques. They used the aProximate™ proximal tubule cell model to assess potential nephrotoxicity and renal transport kinetics.

Find out more

Home › Resources › Videos and webinars › Moving Compounds to IND Using Predictive Retina Models

Moving Compounds to IND Using Predictive Retina Models

During this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

Date: Wednesday 19th June 2024

Speakers:

Dr Lauren Black – Distinguished Scientist/Consultant – Charles River Laboratories
Dr Roxana Redis – Associate Science Director – Charles River Laboratories
Dr Valeria Chichagova – Director of Technology – Newcells Biotech

Published

June 19, 2024

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.

Book a Call